[시장보고서]바이오기술 원료 시장 분석 및 예측(-2035년) : 유형별, 제품 유형별, 서비스별, 기술별, 컴포넌트별, 용도별, 형태별, 공정별, 최종 사용자별

바이오기술 원료 시장 분석 및 예측(-2035년) : 유형별, 제품 유형별, 서비스별, 기술별, 컴포넌트별, 용도별, 형태별, 공정별, 최종 사용자별

Biotech Ingredients Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Form, Process, End User

상품코드 : 1951949

리서치사 : Global Insight Services

발행일 : 2026년 02월

페이지 정보 : 영문 336 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,750

￦ 7,170,000

PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.

US $ 5,750

￦ 8,679,000

PDF & Excel (Site License)

PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.

US $ 6,750

￦ 10,189,000

PDF & Excel (Enterprise License)

PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

바이오기술 원료 시장은 2024년 29억 달러에서 2034년까지 73억 달러로 성장해 CAGR은 약 8.1%를 나타낼 것으로 예측됩니다. 바이오기술 원료 시장은 제약, 화장품 및 식품 산업에 사용되는 바이오 기반 물질의 생산과 활용을 포괄합니다. 생물체에서 추출된 이러한 원료들은 제품 제형 개발에 지속 가능하고 혁신적인 솔루션을 제공합니다. 이 시장은 생명공학의 발전, 천연 제품에 대한 소비자 수요 증가, 친환경 관행에 대한 규제 지원에 힘입어 성장하고 있으며, 이를 통해 다양한 용도에서의 성장과 다각화가 촉진되고 있습니다.

바이오기술 원료 시장은 생명공학의 발전과 지속 가능한 솔루션에 대한 수요 증가에 힘입어 상당한 성장을 앞두고 있습니다. 제약 부문은 혁신적인 의약품 제형 및 맞춤형 의약품에 대한 필요성에 힘입어 가장 우수한 성과를 보이는 하위 부문으로 부상하고 있습니다. 이 부문 내에서 효소는 약물 합성 및 생체 촉매 작용에 활용되면서 주목받고 있습니다. 화장품 및 퍼스널 케어 하위 부문이 그 뒤를 바짝 쫓고 있으며, 펩타이드와 단백질 같은 활성 성분이 제품의 효능과 소비자 매력을 높이고 있습니다. 기능 식품 원료 역시 높아지는 건강 의식과 강화 식품에 대한 수요에 힘입어 상승세를 보이고 있습니다. 프로바이오틱스와 프리바이오틱스는 장 건강과 전반적인 웰빙을 증진시키는 주요 요인으로 두각을 나타내고 있습니다. 바이오기술 기반 향료 및 향은 합성 화합물에 대한 자연적이고 지속 가능한 대안을 제공하며 주목받고 있습니다. 지속적인 R&D 투자와 전략적 협력을 바탕으로 한 시장 성장은 혁신을 촉진하고 제품 개발을 가속화하고 있습니다.

시장 세분화
유형	아미노산, 효소, 비타민, 유기산, 항생제, 호르몬, 바이오폴리머
제품	재조합 단백질, 단일클론항체, 백신, 세포 배양 배지, 바이오의약품, 진단 시약
서비스	위탁 제조, 맞춤 합성, 공정 개발, 분석 서비스, 컨설팅, 규제 대응 지원
기술	발효, 바이오 촉매, 세포 배양, 유전 공학, 합성 생물학, 대사 공학
컴포넌트	원재료, 중간체, 유효성분, 첨가제
용도	의약품, 음식, 농업, 화장품, 사료, 바이오연료
형태	액체, 분말, 과립, 펠릿
공정	업스트림 공정, 다운스트림 공정, 제형, 정제
최종 사용자	제약회사, 생명공학기업, 연구기관, 위탁연구기관

바이오기술 원료 시장은 혁신과 전략적 제휴가 시장 점유율에 주요한 영향을 미치는 역동적인 환경이 특징입니다. 신제품 출시와 비용 효율성 추구에 힘입어 가격 경쟁이 점점 더 치열해지고 있습니다. 최근 출시된 제품들은 제품군을 다양화하여 다양한 분야에서 바이오기술 원료의 매력을 높였습니다. 기업들은 기술 발전을 활용하여 생산 공정을 최적화함으로써 경쟁 우위를 유지하고 지속 가능한 성장을 보장하고 있습니다. 경쟁 벤치마킹 결과, 주요 기업들이 연구 개발을 통해 주도권을 잡기 위해 치열한 경쟁을 벌이고 있는 것으로 나타났습니다. 규제적 영향은 특히 엄격한 안전 및 품질 기준을 적용하는 지역에서 상당합니다. 이러한 규제는 시장 역학을 형성하며, 기업들이 엄격한 규정 준수 조치를 따르도록 강제합니다. 시장은 지속 가능하고 바이오 기반 솔루션에 대한 수요 증가에 힘입어 강력한 성장 잠재력을 보이고 있습니다. 혁신이 계속 가속화됨에 따라, 바이오기술의 발전과 친환경 제품에 대한 소비자 선호에 힘입어 바이오기술 원료 시장은 변혁적인 성장을 앞두고 있습니다.

주요 동향과 촉진요인 :

바이오기술 원료 시장은 지속 가능하고 천연 제품에 대한 수요 증가에 힘입어 눈에 띄는 성장을 보이고 있습니다. 주요 동향으로는 소비자의 친환경 제품 선호에 따른 바이오 기반 원료로의 전환이 있습니다. 이 추세는 고품질의 지속 가능한 원료 생산을 가능하게 하는 바이오기술의 발전에 의해 더욱 뒷받침되고 있습니다. 또 다른 중요한 동향은 맞춤형 영양의 부상으로, 이는 개인의 건강 요구에 맞춘 맞춤형 바이오기술 원료에 대한 수요를 주도하고 있습니다. 또한, 제약 업계가 의약품 제형 개발에 바이오기술 원료에 대한 의존도를 높여가고 있는 점도 중요한 성장 동력입니다. 시장은 또한 향상된 기능을 갖춘 새로운 원료를 개발하기 위한 연구 개발에 대한 투자가 증가하는 모습을 보이고 있습니다. 바이오기술 원료에 대한 수요가 급속히 확대되고 있는 신흥 시장에는 풍부한 기회가 존재합니다. 혁신과 지속 가능성에 주력하는 기업들은 시장 점유율을 확보하기에 유리한 위치에 있습니다. 더불어, 전문성을 활용하고 제품 포트폴리오를 확장하여 이 역동적인 시장에서 경쟁 우위를 확보하기 위해 전략적 파트너십과 협력이 필수적이어지고 있습니다.

시장 규모 및 예측 : 유형별
- 아미노산
- 효소
- 비타민
- 유기산
- 항생제
- 호르몬
- 바이오폴리머
시장 규모 및 예측 : 제품별
- 재조합 단백질
- 단일클론항체
- 백신
- 세포 배양 배지
- 바이오의약품
- 진단 시약
시장 규모 및 예측 : 서비스별
- 위탁 제조
- 맞춤 합성
- 공정 개발
- 분석 서비스
- 컨설팅
- 규제 지원
시장 규모 및 예측 : 기술별
- 발효
- 바이오 촉매
- 세포 배양
- 유전자 공학
- 합성 생물학
- 대사 공학
시장 규모 및 예측 : 컴포넌트별
- 원재료
- 중간체
- 유효성분
- 첨가제
시장 규모 및 예측 : 용도별
- 의약품
- 음식
- 농업
- 화장품
- 동물사료
- 바이오연료
시장 규모 및 예측 : 형태별
- 액체
- 분말
- 과립
- 펠릿
시장 규모 및 예측 : 공정별
- 업스트림 공정
- 다운스트림 공정
- 제형
- 정제
시장 규모 및 예측 : 최종 사용자별
- 제약기업
- 생명공학 기업
- 연구기관
- 위탁연구기관

제5장 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
라틴아메리카
- 브라질
- 아르헨티나
- 기타 라틴아메리카
아시아태평양
- 중국
- 인도
- 한국
- 일본
- 호주
- 대만
- 기타 아시아태평양
유럽
- 독일
- 프랑스
- 영국
- 스페인
- 이탈리아
- 기타 유럽
중동 및 아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 남아프리카
- 서브 사하라 아프리카
- 기타 중동 및 아프리카

제6장 시장 전략

수요 및 공급의 갭 분석
무역 및 물류 제약
가격, 비용 및 마진 동향
시장 침투
소비자 분석
규제 개요

제7장 경쟁 정보

시장 포지셔닝
시장 점유율
경쟁 벤치마킹
주요 기업의 전략

제8장 기업 프로파일

Lonza Group
Catalent
Evonik Industries
Fujifilm Diosynth Biotechnologies
Corbion
Wacker Chemie
Croda International
Novozymes
Merck KGa A
Bio Vectra
Cambrex Corporation
Ajinomoto Bio Pharma Services
Sartorius
Genomatica
Almac Group
Boehringer Ingelheim Bio Xcellence
Ginkgo Bioworks
Biocon
Rentschler Biopharma
AGC Biologics

제9장 회사 소개

HBR

영문 목차

영문목차

Biotech Ingredients Market is anticipated to expand from $2.9 billion in 2024 to $7.3 billion by 2034, growing at a CAGR of approximately 8.1%. The Biotech Ingredients Market encompasses the production and utilization of bio-based substances used in pharmaceuticals, cosmetics, and food industries. These ingredients, derived from living organisms, offer sustainable and innovative solutions for product formulation. The market is driven by advances in biotechnology, increasing consumer demand for natural products, and regulatory support for eco-friendly practices, fostering growth and diversification across applications.

The Biotech Ingredients Market is poised for significant growth, driven by advancements in biotechnology and increasing demand for sustainable solutions. The pharmaceutical segment emerges as the top-performing sub-segment, propelled by the need for innovative drug formulations and personalized medicine. Enzymes, within this segment, are gaining prominence due to their application in drug synthesis and biocatalysis. The cosmetics and personal care sub-segment follows closely, with active ingredients like peptides and proteins enhancing product efficacy and consumer appeal. Functional food ingredients are also witnessing an upward trajectory, fueled by the rising health consciousness and demand for fortified foods. Probiotics and prebiotics stand out as key contributors, promoting gut health and overall well-being. Biotech flavors and fragrances are gaining traction, offering natural and sustainable alternatives to synthetic compounds. The market's growth is underpinned by continuous R&D investments and strategic collaborations, fostering innovation and expediting product development.

Market Segmentation
Type	Amino Acids, Enzymes, Vitamins, Organic Acids, Antibiotics, Hormones, Biopolymers
Product	Recombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Culture Media, Biopharmaceuticals, Diagnostic Reagents
Services	Contract Manufacturing, Custom Synthesis, Process Development, Analytical Services, Consultancy, Regulatory Support
Technology	Fermentation, Biocatalysis, Cell Culture, Genetic Engineering, Synthetic Biology, Metabolic Engineering
Component	Raw Materials, Intermediates, Active Ingredients, Excipients
Application	Pharmaceutical, Food and Beverage, Agriculture, Cosmetics, Animal Feed, Biofuels
Form	Liquid, Powder, Granule, Pellet
Process	Upstream Processing, Downstream Processing, Formulation, Purification
End User	Pharmaceutical Companies, Biotechnology Firms, Research Institutes, Contract Research Organizations

The Biotech Ingredients Market is characterized by a dynamic landscape where market share is primarily influenced by innovation and strategic alliances. Pricing strategies are increasingly competitive, driven by the introduction of novel products and the pursuit of cost efficiency. Recent product launches have diversified offerings, enhancing the appeal of biotech ingredients across various sectors. Companies are leveraging technological advancements to optimize production processes, thereby maintaining a competitive edge and ensuring sustainable growth. Competition benchmarking reveals a market marked by intense rivalry, with key players vying for leadership through research and development. Regulatory influences are significant, particularly in regions with stringent safety and quality standards. These regulations shape market dynamics, compelling companies to adhere to rigorous compliance measures. The market exhibits robust growth potential, fueled by increasing demand for sustainable and bio-based solutions. As innovation continues to accelerate, the biotech ingredients market is poised for transformative growth, driven by advancements in biotechnology and consumer preference for eco-friendly products.

Geographical Overview:

The biotech ingredients market is experiencing notable growth across various regions, each presenting unique opportunities. North America leads, driven by advanced biotech research and a robust pharmaceutical industry. The region's focus on innovation and sustainable practices further propels market growth. Europe follows, with strong regulatory frameworks and investments in biotechnology fostering a conducive environment for market expansion. Asia Pacific is emerging as a significant growth pocket, fueled by increasing investments in biotech research and development. Countries like China and India are at the forefront, leveraging their vast resources and skilled workforce. Latin America and the Middle East & Africa are also gaining traction, with rising awareness and adoption of biotech solutions. Brazil and South Africa are key players, recognizing the potential of biotech ingredients in enhancing various industries. These regions offer lucrative opportunities for stakeholders aiming to capitalize on the burgeoning demand for sustainable and innovative biotech solutions.

Global tariffs and geopolitical risks are significantly influencing the Biotech Ingredients Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are diversifying their supply chains to mitigate tariff impacts, investing in local biotech innovation. China, facing trade tensions, is accelerating the development of its domestic biotech capabilities, while Taiwan's strategic position in the semiconductor industry also affects its biotech sector. The global market for biotech ingredients is robust, driven by demand for innovative pharmaceuticals and sustainable solutions. By 2035, the market is poised for substantial growth, contingent on geopolitical stability and supply chain resilience. Middle East conflicts add complexity, potentially disrupting global supply chains and affecting energy prices, which in turn could influence production costs and timelines in the biotech sector.

Key Trends and Drivers:

The biotech ingredients market is experiencing notable growth, driven by the increasing demand for sustainable and natural products. Key trends include the shift towards bio-based ingredients, fueled by consumer preference for environmentally friendly products. This trend is further supported by advancements in biotechnology, enabling the production of high-quality, sustainable ingredients. Another significant trend is the rise in personalized nutrition, which is driving the demand for customized biotech ingredients tailored to individual health needs. Additionally, the pharmaceutical industry's growing reliance on biotech ingredients for drug formulation is a crucial driver. The market is also witnessing increased investment in research and development to create novel ingredients with enhanced functionalities. Opportunities are abundant in emerging markets, where the demand for biotech ingredients is expanding rapidly. Companies focusing on innovation and sustainability are well-positioned to capture market share. Furthermore, strategic partnerships and collaborations are becoming essential to leverage expertise and expand product portfolios, ensuring competitive advantage in this dynamic market.

Research Scope:

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Services
2.4 Key Market Highlights by Technology
2.5 Key Market Highlights by Component
2.6 Key Market Highlights by Application
2.7 Key Market Highlights by Form
2.8 Key Market Highlights by Process
2.9 Key Market Highlights by End User

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Amino Acids
- 4.1.2 Enzymes
- 4.1.3 Vitamins
- 4.1.4 Organic Acids
- 4.1.5 Antibiotics
- 4.1.6 Hormones
- 4.1.7 Biopolymers
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Recombinant Proteins
- 4.2.2 Monoclonal Antibodies
- 4.2.3 Vaccines
- 4.2.4 Cell Culture Media
- 4.2.5 Biopharmaceuticals
- 4.2.6 Diagnostic Reagents
4.3 Market Size & Forecast by Services (2020-2035)
- 4.3.1 Contract Manufacturing
- 4.3.2 Custom Synthesis
- 4.3.3 Process Development
- 4.3.4 Analytical Services
- 4.3.5 Consultancy
- 4.3.6 Regulatory Support
4.4 Market Size & Forecast by Technology (2020-2035)
- 4.4.1 Fermentation
- 4.4.2 Biocatalysis
- 4.4.3 Cell Culture
- 4.4.4 Genetic Engineering
- 4.4.5 Synthetic Biology
- 4.4.6 Metabolic Engineering
4.5 Market Size & Forecast by Component (2020-2035)
- 4.5.1 Raw Materials
- 4.5.2 Intermediates
- 4.5.3 Active Ingredients
- 4.5.4 Excipients
4.6 Market Size & Forecast by Application (2020-2035)
- 4.6.1 Pharmaceutical
- 4.6.2 Food and Beverage
- 4.6.3 Agriculture
- 4.6.4 Cosmetics
- 4.6.5 Animal Feed
- 4.6.6 Biofuels
4.7 Market Size & Forecast by Form (2020-2035)
- 4.7.1 Liquid
- 4.7.2 Powder
- 4.7.3 Granule
- 4.7.4 Pellet
4.8 Market Size & Forecast by Process (2020-2035)
- 4.8.1 Upstream Processing
- 4.8.2 Downstream Processing
- 4.8.3 Formulation
- 4.8.4 Purification
4.9 Market Size & Forecast by End User (2020-2035)
- 4.9.1 Pharmaceutical Companies
- 4.9.2 Biotechnology Firms
- 4.9.3 Research Institutes
- 4.9.4 Contract Research Organizations

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Services
  - 5.2.1.4 Technology
  - 5.2.1.5 Component
  - 5.2.1.6 Application
  - 5.2.1.7 Form
  - 5.2.1.8 Process
  - 5.2.1.9 End User
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Services
  - 5.2.2.4 Technology
  - 5.2.2.5 Component
  - 5.2.2.6 Application
  - 5.2.2.7 Form
  - 5.2.2.8 Process
  - 5.2.2.9 End User
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Services
  - 5.2.3.4 Technology
  - 5.2.3.5 Component
  - 5.2.3.6 Application
  - 5.2.3.7 Form
  - 5.2.3.8 Process
  - 5.2.3.9 End User
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Services
  - 5.3.1.4 Technology
  - 5.3.1.5 Component
  - 5.3.1.6 Application
  - 5.3.1.7 Form
  - 5.3.1.8 Process
  - 5.3.1.9 End User
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Services
  - 5.3.2.4 Technology
  - 5.3.2.5 Component
  - 5.3.2.6 Application
  - 5.3.2.7 Form
  - 5.3.2.8 Process
  - 5.3.2.9 End User
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Services
  - 5.3.3.4 Technology
  - 5.3.3.5 Component
  - 5.3.3.6 Application
  - 5.3.3.7 Form
  - 5.3.3.8 Process
  - 5.3.3.9 End User
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Services
  - 5.4.1.4 Technology
  - 5.4.1.5 Component
  - 5.4.1.6 Application
  - 5.4.1.7 Form
  - 5.4.1.8 Process
  - 5.4.1.9 End User
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Services
  - 5.4.2.4 Technology
  - 5.4.2.5 Component
  - 5.4.2.6 Application
  - 5.4.2.7 Form
  - 5.4.2.8 Process
  - 5.4.2.9 End User
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Services
  - 5.4.3.4 Technology
  - 5.4.3.5 Component
  - 5.4.3.6 Application
  - 5.4.3.7 Form
  - 5.4.3.8 Process
  - 5.4.3.9 End User
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Services
  - 5.4.4.4 Technology
  - 5.4.4.5 Component
  - 5.4.4.6 Application
  - 5.4.4.7 Form
  - 5.4.4.8 Process
  - 5.4.4.9 End User
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Services
  - 5.4.5.4 Technology
  - 5.4.5.5 Component
  - 5.4.5.6 Application
  - 5.4.5.7 Form
  - 5.4.5.8 Process
  - 5.4.5.9 End User
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Services
  - 5.4.6.4 Technology
  - 5.4.6.5 Component
  - 5.4.6.6 Application
  - 5.4.6.7 Form
  - 5.4.6.8 Process
  - 5.4.6.9 End User
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Services
  - 5.4.7.4 Technology
  - 5.4.7.5 Component
  - 5.4.7.6 Application
  - 5.4.7.7 Form
  - 5.4.7.8 Process
  - 5.4.7.9 End User
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Services
  - 5.5.1.4 Technology
  - 5.5.1.5 Component
  - 5.5.1.6 Application
  - 5.5.1.7 Form
  - 5.5.1.8 Process
  - 5.5.1.9 End User
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Services
  - 5.5.2.4 Technology
  - 5.5.2.5 Component
  - 5.5.2.6 Application
  - 5.5.2.7 Form
  - 5.5.2.8 Process
  - 5.5.2.9 End User
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Services
  - 5.5.3.4 Technology
  - 5.5.3.5 Component
  - 5.5.3.6 Application
  - 5.5.3.7 Form
  - 5.5.3.8 Process
  - 5.5.3.9 End User
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Services
  - 5.5.4.4 Technology
  - 5.5.4.5 Component
  - 5.5.4.6 Application
  - 5.5.4.7 Form
  - 5.5.4.8 Process
  - 5.5.4.9 End User
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Services
  - 5.5.5.4 Technology
  - 5.5.5.5 Component
  - 5.5.5.6 Application
  - 5.5.5.7 Form
  - 5.5.5.8 Process
  - 5.5.5.9 End User
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Services
  - 5.5.6.4 Technology
  - 5.5.6.5 Component
  - 5.5.6.6 Application
  - 5.5.6.7 Form
  - 5.5.6.8 Process
  - 5.5.6.9 End User
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Services
  - 5.6.1.4 Technology
  - 5.6.1.5 Component
  - 5.6.1.6 Application
  - 5.6.1.7 Form
  - 5.6.1.8 Process
  - 5.6.1.9 End User
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Services
  - 5.6.2.4 Technology
  - 5.6.2.5 Component
  - 5.6.2.6 Application
  - 5.6.2.7 Form
  - 5.6.2.8 Process
  - 5.6.2.9 End User
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Services
  - 5.6.3.4 Technology
  - 5.6.3.5 Component
  - 5.6.3.6 Application
  - 5.6.3.7 Form
  - 5.6.3.8 Process
  - 5.6.3.9 End User
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Services
  - 5.6.4.4 Technology
  - 5.6.4.5 Component
  - 5.6.4.6 Application
  - 5.6.4.7 Form
  - 5.6.4.8 Process
  - 5.6.4.9 End User
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Services
  - 5.6.5.4 Technology
  - 5.6.5.5 Component
  - 5.6.5.6 Application
  - 5.6.5.7 Form
  - 5.6.5.8 Process
  - 5.6.5.9 End User

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Lonza Group
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Catalent
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Evonik Industries
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Fujifilm Diosynth Biotechnologies
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Corbion
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Wacker Chemie
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Croda International
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Novozymes
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Merck KGa A
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Bio Vectra
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Cambrex Corporation
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Ajinomoto Bio Pharma Services
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Sartorius
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Genomatica
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 Almac Group
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 Boehringer Ingelheim Bio Xcellence
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Ginkgo Bioworks
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Biocon
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 Rentschler Biopharma
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 AGC Biologics
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us